Reuters logo
BRIEF-CVS Health to increase access to FDA-approved nasal naloxone for patients without insurance
July 29, 2016 / 2:51 PM / a year ago

BRIEF-CVS Health to increase access to FDA-approved nasal naloxone for patients without insurance

July 29 (Reuters) - CVS Health Corp:

* Says to increase access to FDA-approved nasal naloxone for patients without insurance

* CVS Pharmacy patients purchasing Narcan nasal spray without insurance will receive a $35 discount coupon to purchase medication Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below